Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Yasmeen M, Attia"'
Autor:
Mai M. Shaalan, Essam Eldin A. Osman, Yasmeen M. Attia, Olfat A. Hammam, Riham F. George, Bassem H. Naguib
Publikováno v:
ACS Omega, Vol 9, Iss 35, Pp 37310-37329 (2024)
Externí odkaz:
https://doaj.org/article/28b76977d2614297b14c55913c9a2f5b
Autor:
Andrew N. Hakeem, Dina M. El-Kersh, Olfat Hammam, Aliaa Elhosseiny, Amr Zaki, Kohinour Kamel, Lidia Yasser, Marina Barsom, Menatallah Ahmed, Mohamed Gamal, Yasmeen M. Attia
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-16 (2024)
Abstract Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that lacks an actionable target with limited treatment options beyond conventional chemotherapy. Therapeutic failure is often encountered due to inherent or acqui
Externí odkaz:
https://doaj.org/article/2474f191dd58487da9caae3794ea4ed7
Autor:
Andrew N. Hakeem, Mohamed M. Kamal, Rasha A. Tawfiq, Basma A. Abdelrahman, Olfat A. Hammam, Mohamed M. Elmazar, Aiman S. El-Khatib, Yasmeen M. Attia
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 157, Iss , Pp 114050- (2023)
Experimental and clinical evidence implicate disrupted gut barrier integrity in provoking innate immune responses, specifically macrophages, towards the progression of non-alcoholic steatohepatitis (NASH). Peroxisome proliferator-activated receptors
Externí odkaz:
https://doaj.org/article/00581a981a4448b7bff537a608ec3372
Autor:
Dina M. El-Kersh, Shahira M. Ezzat, Maha M. Salama, Engy A. Mahrous, Yasmeen M. Attia, Mahmoud Salama Ahmed, Mohey M. Elmazar
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract Estrogen signaling is crucial for breast cancer initiation and progression. Endocrine-based therapies comprising estrogen receptor (ER) modulators and aromatase inhibitors remain the mainstay of treatment. This study aimed at investigating t
Externí odkaz:
https://doaj.org/article/fed98f29b80b49bd8cc77afe4d8d0f8b
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 33, Iss 1, Pp 858-866 (2018)
Chemical entities with structural diversity were introduced as candidates targeting adenosine receptor with different clinical activities, containing 3,7-dihydro-1H-purine-2,6-dione, especially adenosine 3 receptors (ADORA3). Our initial approach sta
Externí odkaz:
https://doaj.org/article/d6b497e9605749ed903b95d3c34a8c37
Autor:
Andrew N. Hakeem, Mohamed M. Kamal, Rasha A. Tawfiq, Basma A. Abdelrahman, Olfat A. Hammam, Mohamed M. Elmazar, Aiman S. El-Khatib, Yasmeen M. Attia
Publikováno v:
Biomedicinepharmacotherapy = Biomedecinepharmacotherapie. 157
Experimental and clinical evidence implicate disrupted gut barrier integrity in provoking innate immune responses, specifically macrophages, towards the progression of non-alcoholic steatohepatitis (NASH). Peroxisome proliferator-activated receptors
Autor:
Yasmeen M. Attia, Mohamed Mohey Eldin Elmazar, Olfat Hammam, Dalaal M. Abdallah, Rasha A. Tawfiq, Noha N. Nassar
Publikováno v:
Bulletin of Pharmaceutical Sciences. Assiut. 44:265-274
Background: Multiple lines of evidence pointed to the role of dysbiosis, small intestinal bacterial overgrowth and altered intestinal permeability in promoting pro-inflammatory events in the liver leading to the progression of steatosis to non-alcoho
Autor:
Rasha A. Tawfiq, Noha N. Nassar, Olfat A. Hammam, Rasha M. Allam, Mohamed M. Elmazar, Dalaal M. Abdallah, Yasmeen M. Attia
Publikováno v:
Chemico-biological interactions. 361
An interplay exists between non-alcoholic steatohepatitis (NASH) and intestinal barrier dysfunction. A plethora of mechanisms are implicated in the regulation of intestinal integrity, among which is autophagy. Farnesoid X receptor (FXR) is a key meta
Publikováno v:
International Journal of Nanomedicine.
Noha M Badawi,1 Yasmeen M Attia,2 Dina M El-Kersh,3 Olfat A Hammam,4 Maha KA Khalifa5 1Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, The British University in Egypt, Cairo, Egypt; 2Department of Pharmacology, Faculty
Autor:
Mustafa A, Maher, Wafaa A, Kandeel, Olfat A, Hammam, Yasmeen M, Attia, Soheir, Mahmoud, Mohamed, Salah
Publikováno v:
Histology and histopathology. 37(5)
The combination of insulin and DMSO is a patented (Publication No US8987199B2), noninvasive, pharmaceutically strategized preparation for direct nose-to-brain delivery (DN2BD) suggested for the treatment of Alzheimer's disease (AD). Although its main